SEC Form D private-offering filing

GEN1E LIFESCIENCES INC.

Name: GEN1E LIFESCIENCES INC. - new SEC Form D private-offering filing, Palo Alto, CA
Published: 2025-12-29

A new SEC Form D private-offering notice from Palo Alto, CA, a $11,887,377 filer-stated offering target in Biotech. The source filing is one click away.

GEN1E LIFESCIENCES INC. site↗ Verified via SEC Form D

Clinical-stage biotech developing AI-driven precision immunomodulatory therapies for inflammatory and rare diseases, including a Phase 2 program for ARDS and a Duchenne Muscular Dystrophy candidate.

Filed 2025-12-29Filed to raise $11,887,377First money in 2025-10-21Raised so far $5,520,803HQ (as filed) Palo Alto, CASector Biotech ✓Stage (inferred) EarlyCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified gen1e.com↗Named in the filing 5 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.